國立虎尾科技大學 |

Immunotherapy for gastrointestinal cancer

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Immunotherapy for gastrointestinal cancer/ edited by David Kerr, Rebecca Johnson.
其他作者:	Kerr, David.
出版者:	Cham :Springer International Publishing : : 2017.,
面頁冊數:	viii, 252 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
標題:	Gastrointestinal system - Cancer -
電子資源:	http://dx.doi.org/10.1007/978-3-319-43063-8
ISBN:	9783319430638

Immunotherapy for gastrointestinal cancer
Immunotherapy for gastrointestinal cancer[electronic resource] /edited by David Kerr, Rebecca Johnson. - Cham :Springer International Publishing :2017. - viii, 252 p. :ill., digital ;24 cm.

Introduction to modern immunology -- Cell based therapy - modified cancer cells -- Vaccines for GI cancer -- Antibody delivery of radioactive 'warheads' and cytotoxins -- Antibodies which inhibit specific cell pathways -- PD1 and PD1l immune checkpoint inhibitors -- The Role of the JAK/STAT Signaling Pathway in Immunoregulation of Gastrointestinal Cancers -- Hyper mutated colorectal cancer and neoantigen load -- Antibodies which inhibit specific cell pathways, colorectal cancer.

This book is about the manipulation of the immune system as a therapeutic approach to gastrointestinal cancer and its clinical applications, exploring therapeutic approaches which might be taken under the broad banner of immunotherapy. Starting by introducing concepts of modern immunology, the clinical applications of immunotherapy are then discussed. The reader will learn about the three broad classes of immune therapeutic agents: cell-based treatment; antibody therapy; cytokine application and the key effector cells and mechanisms which might cause tumour rejection. The reverse side of this equation, the genetic and molecular mechanisms which the tumour can use to escape immune control and regulation, is also discussed. Through reviewing the most up-to-date evidence, this volume provides an overview of the important scientific lessons learned from past failure of immunotherapeutics in the clinic and highlights more positive recent data, coupled to practical guidelines for clinical usage. Written by a team of worldwide experts, this is an indispensable guide for medical oncologists, surgical oncologists, radiation therapists, pharmacists, oncology nurse specialists.

ISBN: 9783319430638

Standard No.: 10.1007/978-3-319-43063-8doiSubjects--Topical Terms:

1250697
Gastrointestinal system
--Cancer

LC Class. No.: RC280.D5

Dewey Class. No.: 616.994333

Immunotherapy for gastrointestinal cancer
LDR:02598nam a2200313 a 4500 001 958507
003 DE-He213
005 20170816091706.0
006 m d
007 cr nn 008maaau
008 201118s2017 gw s 0 eng d
020 $a 9783319430638 $q (electronic bk.)
020 $a 9783319430614 $q (paper)
024 7 $a 10.1007/978-3-319-43063-8 $2 doi
035 $a 978-3-319-43063-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.D5
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.994333 $2 23
090 $a RC280.D5 $b I33 2017
245 0 0 $a Immunotherapy for gastrointestinal cancer $h [electronic resource] / $c edited by David Kerr, Rebecca Johnson.
260 $a Cham : $c 2017. $b Springer International Publishing : $b Imprint: Springer,
300 $a viii, 252 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction to modern immunology -- Cell based therapy - modified cancer cells -- Vaccines for GI cancer -- Antibody delivery of radioactive 'warheads' and cytotoxins -- Antibodies which inhibit specific cell pathways -- PD1 and PD1l immune checkpoint inhibitors -- The Role of the JAK/STAT Signaling Pathway in Immunoregulation of Gastrointestinal Cancers -- Hyper mutated colorectal cancer and neoantigen load -- Antibodies which inhibit specific cell pathways, colorectal cancer.
520 $a This book is about the manipulation of the immune system as a therapeutic approach to gastrointestinal cancer and its clinical applications, exploring therapeutic approaches which might be taken under the broad banner of immunotherapy. Starting by introducing concepts of modern immunology, the clinical applications of immunotherapy are then discussed. The reader will learn about the three broad classes of immune therapeutic agents: cell-based treatment; antibody therapy; cytokine application and the key effector cells and mechanisms which might cause tumour rejection. The reverse side of this equation, the genetic and molecular mechanisms which the tumour can use to escape immune control and regulation, is also discussed. Through reviewing the most up-to-date evidence, this volume provides an overview of the important scientific lessons learned from past failure of immunotherapeutics in the clinic and highlights more positive recent data, coupled to practical guidelines for clinical usage. Written by a team of worldwide experts, this is an indispensable guide for medical oncologists, surgical oncologists, radiation therapists, pharmacists, oncology nurse specialists.
650 0 $a Gastrointestinal system $x Cancer $x Immunotherapy. $3 1250697
650 1 4 $a Medicine & Public Health. $3 593949
650 2 4 $a Oncology. $3 593951
650 2 4 $a Immunology. $3 592892
650 2 4 $a Gastroenterology. $3 673684
700 1 $a Kerr, David. $3 1117539
700 1 $a Johnson, Rebecca. $3 1250696
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-43063-8
950 $a Medicine (Springer-11650)